Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00114712 · ClinicalTrials.gov registry record
The Ribavirin Pregnancy Registry
A clinical trial, sponsored by Syneos Health.
- Terminated
- Registry status
- 477
- Enrollment target
NCT00114712 is a clinical trial that was terminated before completion, run by Syneos Health. The registered enrollment target is 477 participants.
The verdict
NCT00114712 was terminated before completion, sponsored by Syneos Health.
- TERMINATED
- Registry status
- 477 participants
- Enrollment target
Study Summary
Ribavirin should be avoided during pregnancy and during the 6 months before pregnancy in both the female and the male sexual partner. If a pregnancy occurs and is reported to the Ribavirin Pregnancy Registry, the Registry will follow the pregnant woman throughout pregnancy. The Registry will also follow the infant until 1 year of age. The goal of the Registry is to learn more about the effects of ribavirin on pregnancy and the risk for birth defects. Pregnant women exposed to ribavirin, either by taking ribavirin (during pregnancy or 6 months before pregnancy) or through a male sexual partner (who took ribavirin during the female partner's pregnancy or during the 6 months before pregnancy), are encouraged to contact the Registry.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 477 participants |
| Start Date | 2004-01 |
| Est. Completion | 2020-11-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00114712
The ClinicalTrials.gov registry entry for NCT00114712 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 477 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Syneos Health, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00114712 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00114712 about?
NCT00114712 is a clinical study titled "The Ribavirin Pregnancy Registry". Ribavirin should be avoided during pregnancy and during the 6 months before pregnancy in both the female and the male sexual partner. If a pregnancy occurs and is reported to the Ribavirin Pregnancy Registry, the Registry will follow the pregnant woman throughout pregnancy. The Registry will also fo...
What is the current status of trial NCT00114712?
This trial is currently terminated. The enrollment target is 477 participants. The study started on 2004-01. Estimated completion is 2020-11-02.
Who is sponsoring clinical trial NCT00114712?
This trial is sponsored by Syneos Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.